Blood News and Research

RSS

Rituxan receives FDA approval for treating two rare diseases

The U.S. Food and Drug Administration today approved Rituxan (rituximab), in combination with glucocorticoids (steroids), to treat patients with Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA), two rare disorders that cause blood vessel inflammation (vasculitis).

20 Apr 2011

Diabetes in Control publishes complete list of drugs that affect blood glucose

Any clinician knows that there's a massive amount of new diabetes research and clinical information released daily, which makes keeping pace with best practices almost a full-time job.

20 Apr 2011

Adamis acquires cancer vaccine technology from UCSD

Adamis Pharmaceuticals Corporation (OTCBB: ADMP) today announced the completion of the acquisition of a unique patented cancer vaccine technology from the Regents of the University of California.

20 Apr 2011

Why we 'lust for blood'

We are fascinated with the lurid details of sensational murder trials. Horror fiction and slasher movies thrill us-the gorier the better. When we drive by the scene of an accident, we're compelled to slow down. And it's no secret that brutal video games are solid moneymakers. Why do we thirst for the frighteningly grotesque? In The "LUST FOR BLOOD: WHY WE ARE FASCINATED BY DEATH, MURDER, HORROR, AND VIOLENCE" veteran psychologist Jeffrey A. Kottler explains our dark desire for guts, gore, and the gruesome.

20 Apr 2011

Chronic inflammation due to infection may lead to cancer

A new study shows how inflammation can help cause cancer. Chronic inflammation due to infection or to conditions such as chronic inflammatory bowel disease is associated with up to 25 percent of all cancers.

20 Apr 2011

Cognitive behavior therapy eases depressive symptoms, improves cardiovascular health in diabetics

Frequently, depression and diabetes go hand in hand. And depression can be a major obstacle for people living with diabetes, making it less likely they'll stick to a medicine schedule or exercise regimen.

20 Apr 2011

Antibodies to non-human sugar molecule may be useful for early detection of cancer

Researchers at the University of California, San Diego School of Medicine say antibodies to a non-human sugar molecule commonly found in people may be useful as a future biomarker for predicting cancer risk, for diagnosing cancer cases early and, in sufficient concentration, used as a treatment for suppressing tumor growth.

20 Apr 2011

Tissue Genesis commences PVD clinical trials with adipose-derived adult stem cell-coated vascular grafts

Tissue Genesis, Inc., an emerging leader in adult stem cell and regenerative medicine, announced today that it has begun clinical trials for peripheral vascular disease (PVD) with adipose (fat) derived adult stem cell-coated vascular grafts at the University of Louisville Hospital. Tissue Genesis is the first to initiate a FDA-approved trial using the patient's own adipose-derived adult stem cells (ASCs) prepared at the point-of-care.

20 Apr 2011

Dental diagnosis and treatment for snoring and sleep apnoea

Over seven million people in Spain are at risk of developing sleep apnoea (SA), a health problem caused by obstructed air intake during sleep.

20 Apr 2011

Positive results from first human masitinib phase 2 study in Alzheimer's disease published in peer-reviewed journal

AB Science SA, a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), announces the publication of results from the first human phase 2 study of masitinib carried-out in the treatment of Alzheimer's disease.

20 Apr 2011

Medically vulnerable families can benefit from high-deductible health plans

People who are medically vulnerable -- those with low incomes or chronic health problems -- who enroll in high-deductible health plans are at no more risk for cutting back on needed health care than other people who enroll in the plans, according to a new RAND Corporation study.

20 Apr 2011

Treatment commences in NeuroVive-HCL's 1,000 patient European cardioprotection trial

NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM) cremophor-free IV cyclosporine formulation is used in this study of 1,000 patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue.

20 Apr 2011

Cord blood units treated with signaling molecule show favorable safety profile in long-term animal studies

An innovative experimental treatment for boosting the effectiveness of stem-cell transplants with umbilical cord blood has a favorable safety profile in long-term animal studies, report scientists from Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, and Children's Hospital Boston.

20 Apr 2011

Loyola enrolls patients in clinical trial for open-heart valve replacement surgery

Loyola University Hospital is enrolling patients in a clinical trial that offers an alternative to traditional open-heart surgery for patients who need new aortic heart valves.

20 Apr 2011

FDA approves Rituxan-corticosteroid combination for Wegener's Granulomatosis and Microscopic Polyangiitis

Genentech, a member of the Roche Group and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab), in combination with corticosteroids, as a new medicine for adults with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA).

20 Apr 2011

First hand transplant in western United States

Ms Emily Fennell, a 26-year-old California woman became the first person in the western United States to receive a hand transplant.

19 Apr 2011

Alzheimer’s diagnostic guidelines released

Neurologists and experts have come up with a set of guidelines to better diagnose Alzheimer's disease in the clinic for the first time in nearly three decades. The advice also helps doctors identify the earliest signs of the degenerative condition, even before symptoms of memory loss begin. The hope is that they can help patients prepare early, and eventually treat, the disease.

19 Apr 2011

Parents open to genetic tests for children

Genetic testing techniques have not been perfected yet but parents are willing to take the risk to know if their children are at risk for diseases in adulthood. Some parents would like the ability to predict the future, in terms of their child's risk for certain chronic health conditions. This comes in a new study published online in the journal Pediatrics. Experts, however, say the tests are of little value at this time.

19 Apr 2011

Hangovers affect surgeon's performance

A new study has shown that excessive alcohol consumption, even on the previous day, appears to be associated with changes in some surgical skills performed on virtual reality simulator testing the following day. The study appeared in the April issue of Archives of Surgery, one of the JAMA/Archives journals.

19 Apr 2011

Chembio initiates FDA Modular PMA process for DPP HIV 1/2 Screening Assay

Chembio Diagnostics, Inc., which develops, manufactures, markets and licenses point-of-care diagnostic tests, reported it recently filed the first module of its Pre-Marketing Approval (PMA) application to the United States Food & Drug Administration for its DPP® HIV 1/2 Screening Assay.

19 Apr 2011

Blood News and Research

Rituxan receives FDA approval for treating two rare diseases

Diabetes in Control publishes complete list of drugs that affect blood glucose

Adamis acquires cancer vaccine technology from UCSD

Why we 'lust for blood'

Chronic inflammation due to infection may lead to cancer

Cognitive behavior therapy eases depressive symptoms, improves cardiovascular health in diabetics

Antibodies to non-human sugar molecule may be useful for early detection of cancer

Tissue Genesis commences PVD clinical trials with adipose-derived adult stem cell-coated vascular grafts

Dental diagnosis and treatment for snoring and sleep apnoea

Positive results from first human masitinib phase 2 study in Alzheimer's disease published in peer-reviewed journal

Medically vulnerable families can benefit from high-deductible health plans

Treatment commences in NeuroVive-HCL's 1,000 patient European cardioprotection trial

Cord blood units treated with signaling molecule show favorable safety profile in long-term animal studies

Loyola enrolls patients in clinical trial for open-heart valve replacement surgery

FDA approves Rituxan-corticosteroid combination for Wegener's Granulomatosis and Microscopic Polyangiitis

First hand transplant in western United States

Alzheimer’s diagnostic guidelines released

Parents open to genetic tests for children

Hangovers affect surgeon's performance

Chembio initiates FDA Modular PMA process for DPP HIV 1/2 Screening Assay

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News